Summary
- Venom: The Last Dance had a disappointing box office opening, falling short of early projections.
- Despite negative reviews, the film found success internationally, earning $124 million.
- Analysts attribute the weak performance to the lack of raised stakes compared to previous installments.
Venom: The Last Dance's opening box office gross was lower than expected. However, Tom Hardy's latest Sony Spider-Man Universe film received some respite thanks to the international box office numbers.
Venom: The Last Dance is the concluding installment of a trilogy consisting of two financially successful films: Venom and its sequel, Let There Be Carnage. Both were flops with critics, but audiences flocked to theaters in droves, resulting in a worldwide box office total of $856.1 million for Venom and $506.9 million for Let There Be Carnage (an impressive feat considering the second film was released in the second year of the COVID-19 pandemic). Venom: The Last Dance reviews were also largely negative, but unlike its predecessor, it may have difficulty reaching the same level of box office success after opening with the lowest numbers of the franchise.
Blade MCU Release Date Delay Could Be Longer Than Fans Expected
The Blade MCU release date delay could last longer than most fans want, as a new rumor claims there's a creative reason for the last postponement.
Venom: The Last Dance opened with $51 million at the domestic office, lower than the $65 million it was projected to earn over the weekend. Per Variety, rival studios estimate Venom: The Last Dance's final opening weekend numbers will be lower than $50 million. Even if the $51 million figure holds, Venom: The Last Dance will debut well behind the $80 million Venom earned in its first weekend and the $90 million Let There Be Carnage grossed when it opened. Sony reportedly believes audiences stayed home this past weekend to watch the Yankees and the Dodgers go toe-to-toe at the World Series, despite New York and Los Angeles being Venom: The Last Dance's two biggest markets.
Fortunately for Venom: The Last Dance, it is seemingly a hit outside North America. The threequel earned $124 million internationally, bringing its total to $175 million worldwide. Still, Venom: The Last Dance needs to have legs and stay in theaters to recoup its $120 million budget, as Hollywood projects generally need to earn twice their budget to break even and start making a profit. Exhibitor Relations Jeff Brock told Variety why they felt Venom: The Last Dance didn't entice audiences to the theater. "This was a step down in terms of content, and it was painfully obvious to the audience by the trailers alone," Brock said. "Superhero fans want the stakes raised with each successive installment — that just didn’t happen with ‘The Last Dance.'"
Venom: The Last Dance's underwhelming box office numbers are only the latest example of a trend for comic book movies. In early October, Joker 2 bombed at the box office despite being a sequel to a billion-dollar box office success that earned several accolades, including the Best Actor Academy Award for Joaquin Phoenix's performance as the titular character. Aquaman 2 and The Marvels also underperformed the previous year, falling far behind the $1 billion-plus earned by their predecessors.
Deadpool and Wolverine proved superhero fatigue hasn't entirely overtaken audiences, but its box office success is seemingly an exception for recent comic book movies. Kraven the Hunter is expected to continue Sony's mediocrity when it premieres in December, which would continue the company's record of duds after Morbius and Madame Web tanked financially. Whether Venom: The Last Dance can stick around and prove critics wrong remains to be seen, but fans must head to theaters quickly for it to end its box office run on a high note.
Venom: The Last Dance is now playing in theaters.
Venom: The Last Dance
Display card tags widget Display card community and brand rating widget Display card main info widget- Release Date
- October 25, 2024
Venom 3 is the third and final installment in Sony's symbiote trilogy, starring Tom Hardy as Eddie Brock. It follows the events of Let There Be Carnage, in which the antihero fought serial killer Cletus Kasady, and Spider-Man: No Way Home, in which Brock was briefly transported to the MCU through the multiverse.
MCU: Does Tom Holland's Spider-Man Do More Harm Than Good?
Tom Holland's Spider-Man brings a fun twist to the hero's journey, but does his clumsiness make him more trouble than he’s worth?
Source: Variety